375 related articles for article (PubMed ID: 27609145)
1. Oxidative stress in prostate hyperplasia and carcinogenesis.
Udensi UK; Tchounwou PB
J Exp Clin Cancer Res; 2016 Sep; 35(1):139. PubMed ID: 27609145
[TBL] [Abstract][Full Text] [Related]
2. Oxidative stress parameters in patients with prostate cancer, benign prostatic hyperplasia and asymptomatic inflammatory prostatitis: A prospective controlled study.
Kaya E; Ozgok Y; Zor M; Eken A; Bedir S; Erdem O; Ebiloglu T; Ergin G
Adv Clin Exp Med; 2017 Oct; 26(7):1095-1099. PubMed ID: 29211357
[TBL] [Abstract][Full Text] [Related]
3. Oxidative stress in benign prostatic hyperplasia: a systematic review.
Minciullo PL; Inferrera A; Navarra M; Calapai G; Magno C; Gangemi S
Urol Int; 2015; 94(3):249-54. PubMed ID: 25503259
[TBL] [Abstract][Full Text] [Related]
4. [Oxidative stress in prostate hypertrophy and carcinogenesis].
Przybyszewski WM; Rzeszowska-Wolny J
Postepy Hig Med Dosw (Online); 2009 Jul; 63():340-50. PubMed ID: 19644150
[TBL] [Abstract][Full Text] [Related]
5. Oxidative stress in benign prostatic hyperplasia and prostate cancer.
Pace G; Di Massimo C; De Amicis D; Corbacelli C; Di Renzo L; Vicentini C; Miano L; Tozzi Ciancarelli MG
Urol Int; 2010; 85(3):328-33. PubMed ID: 20484887
[TBL] [Abstract][Full Text] [Related]
6. The controversial relationship between benign prostatic hyperplasia and prostate cancer: the role of inflammation.
De Nunzio C; Kramer G; Marberger M; Montironi R; Nelson W; Schröder F; Sciarra A; Tubaro A
Eur Urol; 2011 Jul; 60(1):106-17. PubMed ID: 21497433
[TBL] [Abstract][Full Text] [Related]
7. The role of oxidative stress in prostate cancer.
Gupta-Elera G; Garrett AR; Robison RA; O'Neill KL
Eur J Cancer Prev; 2012 Mar; 21(2):155-62. PubMed ID: 21857523
[TBL] [Abstract][Full Text] [Related]
8. Metabolic syndrome and prostatic disease: potentially role of polyphenols in preventive strategies. A review.
Castelli T; Russo GI; Reale G; Privitera S; Chisari M; Fragalà E; Favilla V; Cimino S; Morgia G
Int Braz J Urol; 2016; 42(3):422-30. PubMed ID: 27286103
[TBL] [Abstract][Full Text] [Related]
9. [The relationship between oxidative stress and obesity in prostate disease].
Scavuzzo A; Favilla V; Cimino S; Madonia M; Li Volti G; Morgia G
Urologia; 2012; 79(2):156-8. PubMed ID: 22522464
[TBL] [Abstract][Full Text] [Related]
10. Potential role of oxidative stress in pathogenesis of benign prostatic hyperplasia in male dogs.
Domosławska-Wyderska A; Zduńczyk S; Rafalska A
Reprod Domest Anim; 2024 May; 59(5):e14580. PubMed ID: 38698701
[TBL] [Abstract][Full Text] [Related]
11. Oxidative stress and antioxidant status in non-metastatic prostate cancer and benign prostatic hyperplasia.
Aydin A; Arsova-Sarafinovska Z; Sayal A; Eken A; Erdem O; Erten K; Ozgök Y; Dimovski A
Clin Biochem; 2006 Feb; 39(2):176-9. PubMed ID: 16413012
[TBL] [Abstract][Full Text] [Related]
12. Glyoxalase 1-419C>A variant is associated with oxidative stress: implications in prostate cancer progression.
Antognelli C; Mezzasoma L; Mearini E; Talesa VN
PLoS One; 2013; 8(9):e74014. PubMed ID: 24040147
[TBL] [Abstract][Full Text] [Related]
13. Role of oxidative stress response elements and antioxidants in prostate cancer pathobiology and chemoprevention--a mechanistic approach.
Sikka SC
Curr Med Chem; 2003 Dec; 10(24):2679-92. PubMed ID: 14529458
[TBL] [Abstract][Full Text] [Related]
14. [Expressions of endothelin-1 in benign prostatic hyperplasia and prostate cancer and their significance].
Zhou WQ; Sun YH; Yin HL; Zhang ZY; Ge JP; Cheng W; Ma HQ; Wei W; Zhou SG; Ma HH; Gao JP
Zhonghua Nan Ke Xue; 2007 Aug; 13(8):685-9. PubMed ID: 17918704
[TBL] [Abstract][Full Text] [Related]
15. [Expressions of the androgen receptor in normal prostate, benign prostatic hyperplasia and prostate cancer].
Zeng R; Liu ZY; Sun YH; Xu CL; Gao X; Jiao L
Zhonghua Nan Ke Xue; 2010 Nov; 16(11):967-72. PubMed ID: 21218636
[TBL] [Abstract][Full Text] [Related]
16. Oxidative stress and body composition in prostate cancer and benign prostatic hyperplasia patients.
Cimino S; Favilla V; Russo GI; Galvano F; Li Volti G; Barbagallo I; Giofrè SV; D'Orazio N; DI Rosa A; Madonia M; Morgia G
Anticancer Res; 2014 Sep; 34(9):5051-6. PubMed ID: 25202090
[TBL] [Abstract][Full Text] [Related]
17. The Prostate-Associated Gene 4 (PAGE4) Could Play a Role in the Development of Benign Prostatic Hyperplasia under Oxidative Stress.
Li Y; Liu J; Liu D; Wang Z; Zhou Y; Yang S; Guo F; Yang L; Zhang X
Oxid Med Cell Longev; 2022; 2022():7041739. PubMed ID: 35633887
[TBL] [Abstract][Full Text] [Related]
18. [Differentially expressed genes in prostate cancer and benign prostatic hyperplasia].
Zhang T; Xu Y; Tang H; Liu M; Ren D; Niu Y
Zhonghua Nan Ke Xue; 2004 Dec; 10(12):897-9. PubMed ID: 15638016
[TBL] [Abstract][Full Text] [Related]
19. [Expression and its significance of b-FGF in human benign prostatic hyperplasia and prostatic carcinoma tissues].
Wang FL; Wang H; Qin WJ; Wu GJ; Zhang G; Li KN
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Mar; 20(2):203-5. PubMed ID: 15191726
[TBL] [Abstract][Full Text] [Related]
20. Intraprostatic testosterone and dihydrotestosterone. Part I: concentrations and methods of determination in men with benign prostatic hyperplasia and prostate cancer.
van der Sluis TM; Vis AN; van Moorselaar RJ; Bui HN; Blankenstein MA; Meuleman EJ; Heijboer AC
BJU Int; 2012 Jan; 109(2):176-82. PubMed ID: 21992222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
